ProGenerics
PróGenéricos - ProGenericsProGenericsProGenerics

  • Team
  • Associates
  • Biosimilars
  • Generic
  • About
    • News
    • What we stand for
  • Contact
  • Join us
Join us

News

ProGenerics > News
Nov. 25
Categories News
Posted on November 25, 2024November 25, 2024

Hypera receives financing from BNDES for IFA production

Pilot plant will be a factory for high value-added biological medicines The Hypera Pharma Group has obtained approval for...
Read more
data-src="https://progenericos.org.br/src/uploads/2024/11/pexels-maksgelatin-5994627-scaled.jpg"
Nov. 18
Categories News
Posted on November 18, 2024November 18, 2024

Ranking of the most marketed generic drug specialties and therapeutic classes in Brazil 

The survey highlights the main public health needs in the country, with emphasis on the cardiovascular system and the increase...
Read more
data-src="https://progenericos.org.br/src/uploads/2024/11/image.png"
Nov. 11
Categories News
Posted on November 11, 2024November 11, 2024

World Diabetes Day: sales of biosimilars that treat the condition grow by around 32.52% in 2024 

A condition characterized by impaired control of blood glucose levels can affect approximately 21.5 million people...
Read more
data-src="https://progenericos.org.br/src/uploads/2024/11/whatsapp-image-2024-11-05-at-16-21-29-5-3.jpeg"
Nov. 8
Categories News
Posted on November 8, 2024November 8, 2024

25 Years of Geolab: a dream come true

Geolab, a pharmaceutical company founded in 1999, celebrates 25 years of a history marked by dedication and hard work...
Read more
data-src="https://progenericos.org.br/src/uploads/2024/10/pro.jpg"
Oct. 28
Categories News
Posted on October 28, 2024October 28, 2024

PróGenéricos participates in the 5th Global Biosimilars Week promoted by IGBA

The campaign, which runs from November 13 to 17, 2024, aims to mobilize patients, healthcare professionals, and organizations...
Read more
data-src="https://progenericos.org.br/src/uploads/2024/10/2024-09-25-11.png"
Oct. 21
Categories News
Posted on October 21, 2024October 21, 2024

PróGenéricos celebrates 23 years driving the development of the pharmaceutical industry in Brazil

Founded in 2001, the association brings together the leading laboratories specializing in the manufacture and marketing of medicines...
Read more
data-src="https://progenericos.org.br/src/uploads/2024/10/captura-de-tela-2024-10-14-103542.png"
Oct. 14
Categories News
Posted on October 14, 2024October 14, 2024

Signs and symptoms: how to identify osteoporosis

Osteoporosis affects approximately 15 million people in Brazil. Its main causes include calcium deficiency, the...
Read more
data-src="https://progenericos.org.br/src/uploads/2024/10/image.png"
Oct. 11
Categories News
Posted on October 11, 2024October 11, 2024

Awareness and treatment: learn about the generic drugs available for treating thrombosis in Brazil  

Celebrated in October, World Thrombosis Day raises awareness about the condition responsible for more than 100 hospitalizations...
Read more
data-src="https://progenericos.org.br/src/uploads/2024/10/captura-de-tela-2024-10-08-113227.png"
Oct 8
Categories News
Posted on October 8, 2024October 8, 2024

Key changes in the regulation of biosimilar drug registration approved by Anvisa

With the aim of simplifying product development and making registration requirements more flexible, the new regulation is...
Read more
Previous page 1 … 6 7 8 9 10 … 38 Next page

width="350"


Connect, follow and chat with us

progenericos@progenericos.org.br
+55 (61) 3053-7799
+55 (61) 99614-3689
Address:
Edifício Libertas - SAUS Quadra 01 lote 2 Bloco N, SALA 1011 / 1012, Brasília - DF, 70070-010

Follow us

QUICK ACCESS

  • Team
  • Associates
  • What we stand for
  • Biosimilar Medicines
  • Generic Medicines
  • News
  • Privacy Policy
  • Terms of use
  • Português